. Author manuscript; available in PMC: 2018 Oct 30.

Published in final edited form as: Am J Transplant. 2018 Aug 30;18(10):2483–2495. doi: 10.1111/ajt.15040

TABLE 2.

Utility‐related parameters for the Monte Carlo simulation evaluating the cost‐effectiveness of HCV (hepatitis C) treatment timing among kidney transplant candidates

Utility lement	Utility	Range	Source
HCV
F0	0.89	0.75−1	Chong (2003)
F1	0.89	0.75−1	Grieve (2006)
F2	0.89	0.75−1	Stein (2000)^21–23
F3	0.62	0.55−0.75
F4	0.48	0.40−0.60
Toxicity event	−0.16	0.09−0.25
Waitlist	0.525	0.33−1.00	Hogan 2002)³⁹
SVR	0.74−0.92	0.60−1.00	Sherman (2004)⁴⁰
Transplant	0.85	0.50−1.00	Snyder (2013)
			Haller, (2011)
			Hirth, (1999)
			Menzin, (2011)
			Painter, (2013)
			Whiting, (1999)
			Barnieh (2011)^41–48

SVR, Sustained viral response.